FinEdge Labs
I

IONS

IONSReviewed
13 segments tracked|6 years of data|Annual (10-K)
Total Revenue
$1.2B13.5%
FY2024
Operating Segments
13
Active segments
Blended Margin
0.0%
Operating margin
Highest Margin
0.0%
Research And Development Revenue
Segment Shift

Research And Development Revenue has grown from 0.0% to 33.8% of total revenue since FY2019, with 0.0% operating margins. Meanwhile, Ion306 is the fastest growing at 0.0% YoY.

Segment Revenue Over Time

Revenue Mix

Segment Breakdown — FY2024

SegmentRevenueOp. IncomeMargin% of TotalYoY
Research And Development Revenue$412M$00.0%33.8%-14.0%
Collaborative Agreement Revenue$333M$00.0%27.3%-5.7%
Spinraza Royalties$216M$00.0%17.7%-10.1%
Wainua Joint Development Revenue$79M$00.0%6.5%-37.2%
Ion306$60M$00.0%4.9%+0.0%
Ion826$36M$00.0%3.0%+0.0%
Attrv Pn$30M$00.0%2.5%-40.0%
Other$23M$00.0%1.9%+0.0%
Wainus Royalties$20M$00.0%1.7%+0.0%
Qalsody$10M$00.0%0.8%+0.0%

Want more? Unlock the full analysis.

Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.

Get Started Free